Business Context and Reporting Period
Company: NUR Macroprinters Ltd. (Note: Request metadata listed "Ellomay Capital Ltd.", but the filing text identifies the registrant as NUR Macroprinters Ltd.)
Filing Type: Form 20-F (Annual Report)
Period: Fiscal year ended December 31, 2002
Business Overview: NUR is a leading supplier of wide format and super wide format digital printing systems (printers, inks, and substrates) for on-demand, short-run printing. The company operates globally with subsidiaries in Europe, North America, South America, and the Asia Pacific region. Key products include the NUR Blueboard, NUR Fresco, and NUR Salsa printer families.
Key Financial Metrics (Year Ended Dec 31, 2002)
| Metric | 2002 (in thousands USD) | 2001 (in thousands USD) |
|---|---|---|
| Revenues | $85,255 | $120,377 |
| Gross Profit | $26,920 | $44,460 |
| Gross Margin | 31.6% | 37.0% |
| Operating Loss | $(22,585) | $(3,901) |
| Net Loss | $(24,065) | $(7,216) |
| Net Loss Per Share (Basic/Diluted) | $(1.42) | $(0.49) |
| Working Capital | $36,711 | $41,934 |
| Total Assets | $87,895 | $111,096 |
| Total Liabilities | $64,735 | $70,099 |
| Shareholders' Equity | $23,160 | $40,997 |
| Cash and Cash Equivalents | $10,505 | $12,395 |
Material Changes vs. Prior Period
- Revenue Decline: Revenues decreased by approximately 29% ($35.1 million) compared to 2001. This was attributed to a weakened macroeconomic environment, reduced capital equipment investment by customers, heightened competition, and price reductions.
- Significant Impairments: The company recognized a total impairment of $10.87 million on intangible assets (goodwill and technology) in 2002 due to the adoption of SFAS No. 142 and SFAS No. 144. This included a $3.8 million goodwill impairment and a $7.0 million technology impairment.
- Restructuring and One-Time Charges: The company incurred $1.3 million in restructuring charges and $2.9 million in doubtful debt expenses related to the relocation of Asia Pacific operations from Shanghai to Hong Kong. Additionally, a $1.0 million inventory write-off was recorded.
- Geographic Shifts: Revenues from China dropped significantly from $13.5 million in 2001 to $4.4 million in 2002 due to operational difficulties and the subsequent relocation of the regional headquarters.
Guidance, Outlook, Risks, and Unusual Items
- Liquidity and Financing Needs: The company incurred operating losses for several consecutive quarters and requires additional funds to expand operations or meet revenue expectations. There are no current commitments for additional financing.
- Bank Covenant Defaults: NUR failed to meet certain financial ratios required by its long-term loan agreements with Bank Hapoalim and Bank Leumi due to revenue declines. The banks agreed in writing not to act on these defaults, and in March 2003, amended the covenants to better align with the company's business plan.
- Nasdaq Listing Status: In November 2002, NUR received a compliance notice from Nasdaq for failing to maintain the $1.00 minimum bid price. The company was unable to regain compliance by the May 5, 2003 deadline and applied to transfer its securities to the Nasdaq SmallCap Market. Failure to list on SmallCap could result in trading on the OTC Bulletin Board ("pink sheets"), reducing liquidity.
- Supply Chain Risks: The company relies on sole-source suppliers for inkjet printheads (Imaje S.A. and Modular Ink Technology). Production delays or supply issues could materially harm financial results.
- Unusual Items:
- Derivative Losses: Non-hedging forward and options contracts resulted in a loss of approximately $1.6 million in 2002.
- Legal Settlements: Settled a lawsuit with Poalim Capital Markets by issuing warrants and settled a claim with Abudi Signage Industry for $0.14 million.
Investor Verification Checklist
- Debt Covenant Compliance: Verify the company's ability to meet the newly amended financial ratios (equity levels, cash balances, EBITDA) required by Bank Hapoalim and Bank Leumi to avoid immediate repayment demands.
- Capital Raising: Assess the company's ability to secure additional equity or debt financing given the lack of current commitments and the recent stock price volatility.
- Nasdaq Transfer Approval: Confirm the status of the application to transfer to the Nasdaq SmallCap Market and the potential impact on stock liquidity if the transfer is denied.
- China Operations: Evaluate the success of the new distribution strategy in China (via CAST) following the relocation of the Asia Pacific headquarters to Hong Kong.
- Product Pipeline: Monitor the commercial release and market acceptance of the NUR Ultima HiQ and NUR Tempo printers, which are critical for future revenue growth.